Tuesday, April 29, 2014

Sex and Race Discrimination in Academia Starts Even Before Grad School

Sex and Race Discrimination in Academia Starts Even Before Grad School
Scientific American: Mind and Brain

A study of how likely faculty were to respond to a request to meet with a student to discuss research opportunities found that professors were more likely to respond to white men than women and...

-- Read more on ScientificAmerican.com


Original Article: http://www.scientificamerican.com/article/sex-and-race-discrimination-in-academia-starts-even-before-grad-school/

Saturday, April 26, 2014

Mutant IDH1 inhibits PI3K/Akt signaling in human glioma

Mutant IDH1 inhibits PI3K/Akt signaling in human glioma
Cancer

BACKGROUND

Recently, isocitrate dehydrogenase 1 (IDH1) was identified as a major participant in glioma pathogenesis. At present, the enzymatic activity of the protein has been the main topic in investigating its physiological function, but its signaling pathway allocation was unsuccessful. Interestingly, proteins regulated by phosphoinositide 3-kinase (PI3K)/Akt signaling, are among the top downregulated genes in gliomas associated with high percentage of IDH1 and IDH2 mutations. The aim of this study was to investigate a hypothetical relation between IDH1 and PI3K signaling.

METHODS

The presence of mutant IDH1 and markers for active PI3K/Akt signaling, present as phosphorylated Akt and podoplanin (PDPN), were investigated in a discovery cohort of 354 patients with glioma. In vitro experiments were used to confirm functional links.

RESULTS

This study shows an inverse correlation between mutant IDH1 and markers for active PI3K/Akt signaling. In support of a functional link between these molecules, in vitro expression of mutant IDH1 inhibited Akt phosphorylation in a 2-hydroxyglutarate–dependent manner.

CONCLUSIONS

This study provides patient tumor and in vitro evidence suggesting that mutant IDH1 inhibits PI3K/Akt signaling. Cancer 2014. © 2014 American Cancer Society.



Original Article: http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002/cncr.28732

Thursday, April 24, 2014

Ambient Music Eases Pain

Ambient Music Eases Pain
Scientific American: Mind and Brain

Soothing music helps patients heal after an operation

-- Read more on ScientificAmerican.com


Original Article: http://www.scientificamerican.com/article/ambient-music-eases-pain/

Wednesday, April 23, 2014

Confira no iTunes: Após Um Tumor Cerebral

Confira livro no iTunes:

artwork

APÓS UM TUMOR CEREBRAL

Júlio Pereira

Medicina, Livros, Profissional e técnico

23/01/2010

Visualizar Item

Esta obra narra a história de um médico neurocirurgião que descobre que tem um tumor cerebral, após essa descoberta ele resolveu escrever um livro sobre seu dia-dia lidando com doentes graves. O livro vai revelando o médico e seus pacientes, cada um deles com seus medos e suas preocupações.

Você não foi adicionado a nenhuma lista de e-mail.

Copyright © 2014 Apple Inc. Todos os direitos reservados.

Significance of Cochlear Dose in the Radiosurgical Treatment of Vestibular Schwannoma: Controversies and Unanswered Questions

Significance of Cochlear Dose in the Radiosurgical Treatment of Vestibular Schwannoma: Controversies and Unanswered Questions
Neurosurgery - Current Issue

imageBACKGROUND: Cochlear dose has been identified as a potentially modifiable contributor to hearing loss after stereotactic radiosurgery (SRS) for vestibular schwannoma (VS). OBJECTIVE: To evaluate the association between computed tomography-based volumetric cochlear dose and loss of serviceable hearing after SRS, to assess intraobserver and interobserver reliability when determining modiolar point dose with the use of magnetic resonance imaging and computed tomography, and to discuss the clinical significance of the cochlear dose with regard to radiosurgical planning strategy. METHODS: Patients with serviceable pretreatment hearing who underwent SRS for sporadic VS between the use of Gamma Knife Perfexion were studied. Univariate and multivariate associations with the primary outcome of time to nonserviceable hearing were evaluated. RESULTS: A total of 105 patients underwent SRS for VS during the study period, and 59 (56%) met study criteria and were analyzed. Twenty-one subjects (36%) developed nonserviceable hearing at a mean of 2.2 years after SRS (SD, 1.0 years; median, 2.1 years; range 0.6-3.8 years). On univariate analysis, pretreatment pure tone average, speech discrimination score, American Academy of Otolaryngology-Head and Neck Surgery hearing class, marginal dose, and mean dose to the cochlear volume were statistically significantly associated with time to nonserviceable hearing. However, after adjustment for baseline differences, only pretreatment pure tone average was statistically significantly associated with time to nonserviceable hearing in a multivariable model. CONCLUSION: Cochlear dose is one of many variables associated with hearing preservation after SRS for VS. Until further studies demonstrate durable tumor arrest with reduced dose protocols, routine tumor dose planning should not be modified to limit cochlear dose at the expense of tumor control. ABBREVIATIONS: AAO-HNS, American Academy of Otolaryngology-Head and Neck Surgery CI, confidence interval PTA, pure tone average SDS, speech discrimination score SRS, stereotactic radiosurgery VS, vestibular schwannoma

Original Article: http://journals.lww.com/neurosurgery/Fulltext/2014/05000/Significance_of_Cochlear_Dose_in_the_Radiosurgical.2.aspx

Surgically Relevant Localization of the Central Sulcus With High-Density Somatosensory-Evoked Potentials Compared With Functional Magnetic Resonance Imaging

Surgically Relevant Localization of the Central Sulcus With High-Density Somatosensory-Evoked Potentials Compared With Functional Magnetic Resonance Imaging
Neurosurgery - Current Issue

imageBACKGROUND: Resection of abnormal brain tissue lying near the sensorimotor cortex entails precise localization of the central sulcus. Mapping of this area is achieved by applying invasive direct cortical electrical stimulation. However, noninvasive methods, particularly functional magnetic resonance imaging (fMRI), are also used. As a supplement to fMRI, localization of somatosensory-evoked potentials (SEPs) recorded with an electroencephalogram (EEG) has been proposed, but has not found its place in clinical practice. OBJECTIVE: To assess localization accuracy of the hand somatosensory cortex with SEP source imaging. METHODS: We applied electrical source imaging in 49 subjects, recorded with high-density EEG (256 channels). We compared it with fMRI in 18 participants and with direct cortical electrical stimulation in 6 epileptic patients. RESULTS: Comparison of SEP source imaging with fMRI indicated differences of 3 to 8 mm, with the exception of the mesial-distal orientation, where variances of up to 20 mm were found. This discrepancy is explained by the fact that the source maximum of the first SEP peak is localized deep in the central sulcus (area 3b), where information initially arrives. Conversely, fMRI showed maximal signal change on the lateral surface of the postcentral gyrus (area 1), where sensory information is integrated later in time. Electrical source imaging and fMRI showed mean Euclidean distances of 13 and 14 mm, respectively, from the contacts where electrocorticography elicited sensory phenomena of the contralateral upper limb. CONCLUSION: SEP source imaging, based on high-density EEG, reliably identifies the depth of the central sulcus. Moreover, it is a simple, flexible, and relatively inexpensive alternative to fMRI. ABBREVIATIONS: DCES, direct cortical electrical stimulation EEG, electroencephalography ESI, electric source imaging fMRI, functional magnetic resonance imaging GFP, global field power HD, high density MEG, magnetoencephalogram MNI, Montreal Neurological Institute SEP, somatosensory evoked potential SI, primary somatosensory cortex

Original Article: http://journals.lww.com/neurosurgery/Fulltext/2014/05000/Surgically_Relevant_Localization_of_the_Central.6.aspx

Intraoperative Contrast-Enhanced Ultrasound for Brain Tumor Surgery

Intraoperative Contrast-Enhanced Ultrasound for Brain Tumor Surgery
Neurosurgery - Current Issue

imageBACKGROUND: Contrast-enhanced ultrasound (CEUS) is a dynamic and continuous modality that offers a real-time, direct view of vascularization patterns and tissue resistance for many organs. Thanks to newer ultrasound contrast agents, CEUS has become a well-established, live-imaging technique in many contexts, but it has never been used extensively for brain imaging. The use of intraoperative CEUS (iCEUS) imaging in neurosurgery is limited. OBJECTIVE: To provide the first dynamic and continuous iCEUS evaluation of a variety of brain lesions. METHODS: We evaluated 71 patients undergoing iCEUS imaging in an off-label setting while being operated on for different brain lesions; iCEUS imaging was obtained before resecting each lesion, after intravenous injection of ultrasound contrast agent. A semiquantitative, offline interobserver analysis was performed to visualize each brain lesion and to characterize its perfusion features, correlated with histopathology. RESULTS: In all cases, the brain lesion was visualized intraoperatively with iCEUS. The afferent and efferent blood vessels were identified, allowing evaluation of the time and features of the arterial and venous phases and facilitating the surgical strategy. iCEUS also proved to be useful in highlighting the lesion compared with standard B-mode imaging and showing its perfusion patterns. No adverse effects were observed. CONCLUSION: Our study is the first large-scale implementation of iCEUS in neurosurgery as a dynamic and continuous real-time imaging tool for brain surgery and provides the first iCEUS characterization of different brain neoplasms. The ability of CEUS to highlight and characterize brain tumor will possibly provide the neurosurgeon with important information anytime during a surgical procedure. ABBREVIATIONS: CE, contrast enhancement CEUS, contrast-enhanced ultrasound EFSUMB, European Federation of Societies for Ultrasound in Medicine and Biology 5-ALA, 5-aminolevulinic acid iCEUS, intraoperative contrast-enhanced ultrasound UCA, ultrasound contrast agent; US, ultrasound

Original Article: http://journals.lww.com/neurosurgery/Fulltext/2014/05000/Intraoperative_Contrast_Enhanced_Ultrasound_for.9.aspx

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?
Radiation Oncology

ObjectiveLong-term survival is rare in patients with glioblastoma (GBM). We set out to determine prognostic factors for patients with favorable and poor prognosis in regard of tumor localization to the subventricular zone (SZV). Methods: We reviewed the clinical records, pre-operative and post-operative MRI imaging of 50 LTS long-term survivors (LTS) (>3 years) and 50 short-term survivors (STS) (<1 year) with glioblastoma. These groups were matched for clinical characteristics being consistently associated with prolonged or shortened survival. All patients had undergone initial surgery or biopsy to confirm GBM diagnosis followed by radio- or chemoradiotherapy. Results: LTS had a median progression-free survival PFS of 25,4 months (2,3 - 97,8 months) and overall-survival (OS) of 55,9 months (38,2 - 98,6 months) compared to STS who had a significantly lower PFS of 4,2 months (1,4 - 10,2 months) and OS of 6,6 months (2,2 - 11,6 months) (each p < 0,001).Survival analysis showed that age under 60 years (p < 0,001), total resection status (p < 0,001) and tumor localization without SVZ contact (p = 0,05) were significant factors for prolonged survival. Conclusion: Our findings underline that survival in GBM patients is heterogeneous and influenced by multiple factors. This study confirms that tumor location with regard to the SVZ is significantly associated with survival.

Original Article: http://www.ro-journal.com/content/9/1/95

Acetazolamide helps improve vision for patients with idiopathic intracranial hypertension

Acetazolamide helps improve vision for patients with idiopathic intracranial hypertension
Neurology News & Neuroscience News from Medical News Today

In patients with idiopathic intracranial hypertension and mild vision loss, the use of the drug acetazolamide, along with a low-sodium weight-reduction diet, resulted in modest improvement in...

Original Article: http://www.medicalnewstoday.com/releases/275780.php

Monday, April 21, 2014

Tratamento: abraço quentinho ( Contos de Gerson Salvador)

Tratamento: abraço quentinho ( Contos de Gerson Salvador)
Neurosurgery Blog

Tratamento: abraço quentinho
Autor: Gerson Salvador
Era uma tarde de um tempo de um frio julho. Chegou no pronto socorro infantil do Hospital da Universidade uma bebê de três meses com desconforto respiratório.
O pai tivera diagnóstico de tuberculose pulmonar havia poucos dias, bacilos quatro cruzes.
A criança foi colocada em observação na tenda de oxigênio, sob isolamento respiratório.  Aguarda pesquisa de bacilos. Frio julho.
Passam as horas, a partir das dezenove troca a turma dos internos de plantão, os médicos-estagiários com certas caras de crianças. Foi a interna do quinto ano quem percebeu através do vidro da porta de isolamento que a criança não se mexia, estava roxinha! 
O coração acelerou. Ela ainda não sabia agir como médica. Balbuciou um pedido de ajuda: eu quero meu assistente! Entrou no isolamento respiratório sem máscara e percebeu a paciente azul, encolhida, parada cardiorrespiratória?
Vontade de chorar. Não se recolhe!
Ela pega a criança, percebe que está gelada abraça apertado, encosta no peito com uma cobertinha. E corre para a sala de emergência talvez por não saber o que fazer. 
O caminho parecia infinito, talvez uns doze metros.
Azul.
Ciano.
Roxo.
Violeta.
Vermelho.
Rosa.
Rosa!
Era hipotermia.
Há essas massas polares que envolvem as pessoas. 
Antes de chegar à sala de emergência, antes que chegasse qualquer ajuda, a criança ficou quentinha no colo dela, se mexeu, gemeu, fez barulhinhos estranhos com a boquinha e deu um sorriso social.
Como é lindo esse desenvolvimento neuropsicomotor!

xxxxxxxxxx

1471736_10202264061263627_940202081_n

Dr. Gerson Salvador
Médico infectologista Universidade de São Paulo
Disciplina de propedeutica médica Faculdade de Medicina da USP
Médico da divisão de Clínica Médica Hospital Universitário da USP

Contatos:

Facebook: https://www.facebook.com/gerson.salvadordeoliveira

twitter @gersonsalvador

email:  gersonsalvador@gmail.com

 

Outros Contos de Gerson Salvador:

http://neurocirurgiabr.com/de-barquinho-para-o-ceu-contos-de-gerson-salvador/

http://neurocirurgiabr.com/o-pior-medico-do-mundo-contos-de-gerson-salvador/

http://neurocirurgiabr.com/descompensacao-contos-de-gerson-salvador/

http://neurocirurgiabr.com/gasometria-contos-de-gerson-salvador/

http://neurocirurgiabr.com/dor-toracica-contos-de-gerson-salvador/

The post Tratamento: abraço quentinho ( Contos de Gerson Salvador) appeared first on NEUROSURGERY BLOG.



Original Article: http://neurocirurgiabr.com/tratamento-abraco-quentinho-contos-de-gerson-salvador/?utm_source=rss&utm_medium=rss&utm_campaign=tratamento-abraco-quentinho-contos-de-gerson-salvador

Brain Metastases In Ovarian Cancer- A Comprehensive Review (P7.254)

Brain Metastases In Ovarian Cancer- A Comprehensive Review (P7.254)
Neurology recent issues

OBJECTIVE: To review the literature on brain metastasis (BM) from ovarian cancer, and assess the frequency, anatomical, clinical and paraclinical information and factors associated with prognosis.BACKGROUND: Ovarian cancer is a rare cause of brain metastasis. Progressive neurologic disability often results and the prognosis is generally poor. A comprehensive review on this subject has not been published previously.DESIGN/METHODS:This systematic literature search used the Pubmed and Yale library search engine and included all relevant articles in English literature. A total of 66 publications were found, 57 of which were used representing 591 patients with BM from ovarian cancer.RESULTS: The median age of the patients was 54.3 years (range 20-81). A majority of patients (57.3%) had multiple brain lesions. The location of the lesion was cerebellar( 30%), frontal (20%), parietal (18%) and occipital (11% ) . Extracranial metastasis was present in 49.8% of cases involving liver (20.7%), lung(20.4%), lymph nodes (12.6%), bones (6.6%) and pelvic organs (4.3%). The most common symptoms were weakness (16%), seizures (11%), altered mentality (11%) visual disturbances (9%) and dizziness (8%). The interval from diagnosis of breast cancer to BM ranged from 0-133 months (median 24 ) and median survival was 8.2 months. Treatment included local radiation, surgical resection, stereotactic radiosurgery and medical therapy. Factors that significantly increased the survival were younger age at the time of ovarian cancer diagnosis and at the time of brain metastasis diagnosis, higher KPS score and multimodality treatment for the brain metastases.CONCLUSIONS:Ovarian cancer is a rare cause of brain metastasis. Development of brain metastasis among older patients and lower KPS score correlate with less favorable prognosis. The more prolonged survival after using multimodality treatment for brain metastasis is important information that can potentially impact the management of such brain metastasis in future.Study Supported by: no support

Disclosure: Dr. Pakneshan has nothing to disclose. Dr. Safarpour has nothing to disclose. Dr. Tavassoli has nothing to disclose. Dr. Jabbari has received research support from Allergan Inc., Merz Pharma, and Ipsen.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/P7.254?rss=1

Early retirement in cancer patients with or without comorbid mental health conditions: A prospective cohort study

Early retirement in cancer patients with or without comorbid mental health conditions: A prospective cohort study
Cancer

BACKGROUND

The authors investigated whether cancer patients who have comorbid mental health disorders (MD) are at greater risk of early retirement compared with those who do not have MD.

METHODS

Individuals ages 18 to 55 years from a consecutive sample of patients who were admitted for inpatient oncologic treatment were interviewed using structured clinical interviews to ascertain MD. The patients were followed for 15 months, and the date of early retirement was documented. Rates of early retirement per 100 person-years (py) in patients with and without MD were compared using multivariate Poisson regression models.

RESULTS

At baseline, 491 patients were interviewed, and 150 of those patients (30.6%) were diagnosed with MD. Forty-one patients began full early retirement during follow-up. In patients with MD, the incidence of early retirement was 9.3 per 100 py compared with 6.1 per 100 py in mentally healthy patients. The crude rate ratio (RR) was 1.5 (95% confidence interval [CI], 0.8-2.8). The effect of MD on early retirement was modified in part by income: in patients with low income, the adjusted RR was 11.7, whereas no effect was observed in higher income groups. Patients with depression were at greater risk of retirement when they had higher income (RR, 3.4; P = .05). The effects of anxiety (RR, 2.4; P = .05), adjustment disorders (RR, 1.7; P = .21), and alcohol dependence (RR, 1.8; P = .40) on early retirement were equal across income groups.

CONCLUSIONS

Mental health conditions are risk factors for early retirement in cancer patients, although this effect differs according to the type of disorder and the patient's income level. Cancer 2014. © 2014 American Cancer Society.



Original Article: http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002/cncr.28716

Thursday, April 17, 2014

Survival and Neurocognitive Outcomes After Cranial or Craniospinal Irradiation Plus Total-Body Irradiation Before Stem Cell Transplantation in Pediatric Leukemia Patients With Central Nervous System Involvement

Survival and Neurocognitive Outcomes After Cranial or Craniospinal Irradiation Plus Total-Body Irradiation Before Stem Cell Transplantation in Pediatric Leukemia Patients With Central Nervous System Involvement
International Journal of Radiation Oncology * Biology * Physics

Purpose: To evaluate survival and neurocognitive outcomes in pediatric acute lymphoblastic leukemia (ALL) patients with central nervous system (CNS) involvement treated according to an institutional protocol with stem cell transplantation (SCT) and a component of craniospinal irradiation (CSI) in addition to total-body irradiation (TBI) as preparative regimen.Methods and Materials: Forty-one pediatric ALL patients underwent SCT with TBI and received additional cranial irradiation or CSI because of CNS leukemic involvement. Prospective neurocognitive testing was performed before and after SCT in a subset of patients. Cox regression models were used to determine associations of patient and disease characteristics and treatment methods with outcomes.Results: All patients received a cranial radiation boost; median total cranial dose was 24 Gy. Eighteen patients (44%) received a spinal boost; median total spinal dose for these patients was 18 Gy. Five-year disease-free survival (DFS) for all patients was 67%. Those receiving CSI had a trend toward superior DFS compared with those receiving a cranial boost alone (hazard ratio 3.23, P=.14). Patients with isolated CNS disease before SCT had a trend toward superior DFS (hazard ratio 3.64, P=.11, 5-year DFS 74%) compared with those with combined CNS and bone marrow disease (5-year DFS 59%). Neurocognitive testing revealed a mean post-SCT overall intelligence quotient of 103.7 at 4.4 years. Relative deficiencies in processing speed and/or working memory were noted in 6 of 16 tested patients (38%). Pre- and post-SCT neurocognitive testing revealed no significant change in intelligence quotient (mean increase +4.7 points). At a mean of 12.5 years after transplant, 11 of 13 long-term survivors (85%) had completed at least some coursework at a 2- or 4-year college.Conclusion: The addition of CSI to TBI before SCT in pediatric ALL with CNS involvement is effective and well-tolerated. Craniospinal irradiation plus TBI is worthy of further protocol investigation in children with CNS leukemia.

Original Article: http://www.redjournal.org/article/S0360-3016(14)00184-9/abstract?rss=yes

Occipital Headaches and Neuroimaging in Children (P4.324)

Occipital Headaches and Neuroimaging in Children (P4.324)
Neurology recent issues

OBJECTIVE:To determine the implications of occipital headache in children and clarify when imaging is indicated.BACKGROUND:Occipital headache in children is considered a warning sign of intracranial pathology. The new ICHD-3 beta criteria for migraine state, "Occipital headache in children is rare and calls for diagnostic caution." Support for this comes from studies in emergency departments rather than neurologists' offices.DESIGN/METHODS:We performed a retrospective chart review cohort study of all patients referred to a child neurology clinic for headache in 2009. Patients were stratified by headache location: solely occipital, occipital plus other area(s) of head pain, or no occipital involvement. We assessed location as a predictor of 1) whether neuroimaging was ordered, and 2) whether intracranial pathology was found. Analyses were performed using logistic regression, Chi-Square, and Fisher's exact tests.RESULTS:A total of 356 patients were included. Median age was 12.1 years (27 months to 18 years), and 56.5% were female. Headaches were solely occipital in 6.4% and occipital-plus in 13.2%. Patients with occipital head pain were more likely to undergo neuroimaging than those without occipital involvement (solely occipital: 91%, RR 4.9, 95% CI 1.2-20.6; occipital-plus: 85%, RR 2.7, 95% CI 1.2-5.8; no occipital pain: 65%, ref.). Occipital pain alone or with other locations was not significantly associated with radiographic evidence of elevated intracranial pressure, tumor, benign cyst, or sinusitis. Occipital pain was associated with Chiari I malformation (solely occipital: RR 4, 95% CI 1.2-13.5; occipital-plus: RR 3.3, 95% CI 1.5-6.9).CONCLUSIONS:Children with occipital headache are more likely to undergo neuroimaging. In our study, occipital pain was associated with Chiari I malformation but not with more serious intracranial pathology. Detecting a Chiari I malformation is useful only if the clinical presentation is consistent with tonsillar compression; otherwise, it may be an incidental finding in a child with migraine. Without a worrying history and with a normal examination, neuroimaging can be deferred in most pediatric patients when occipital pain is present.

Disclosure: Dr. Bear has nothing to disclose. Dr. Gelfand has received personal compensation in an editorial capacity for Journal Watch Neurology. Dr. Goadsby has received personal compensation for activities with Allergan, Inc., Colucid, MAP Pharmaceuticals, Merck Sharp & Dohme Limited, eNeura, ATI, Boston Scientific Corporation, Eli Lilly & Company, Medtronic, Inc., Bristol-Myers Squibb Company, Amgen Inc., Arteaus, AlderBio, Pfizer Inc., Zogeniz, Nevrocorp, Ipmax, DrReddy, and Zosano. Dr. Goadsby has received research support from Amgen Inc., Merck Sharp & Dohme Limited, and Allergan, Inc. Dr. Bass has nothing to disclose.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/P4.324?rss=1

Wednesday, April 16, 2014

Utility of CT Perfusion (CTP) Imaging in Seizures: A Retrospective Analysis and Literature Review (P3.005)

Utility of CT Perfusion (CTP) Imaging in Seizures: A Retrospective Analysis and Literature Review (P3.005)
Neurology recent issues

Objective: To elucidate specific patterns in CTP that can delineate seizure from stroke. Background: CT Perfusion (CTP) has fast become the imaging modality of choice in acute stroke. It can also shed light on stroke mimics (seizures, PRES). Many peculiar CTP changes in relation to seizures have been reported in the literature. Our study sought to delineate the specificities on CTP that can aid in the above objective. Methods: We retrospectively identified patients who presented to our center as stroke alerts but received a discharge diagnosis of seizure between 2008 and 20011. We excluded patients who did not get a CTP or EEG. We compared the patient's CTP with their EEG and MRI. Results: 91% of patients who presented with seizure, had an abnormal CTP. Of these 66% had typical CTP changes suggestive of seizure i.e. ipsilateral increased perfusion, or contralateral increased Time To Peak (TTP), or unilateral increased Cerebral Blood Flow (CBF) and decreased TTP. A minority showed globally increased CBF with EEG showing status epilepticus. The Pattern of perfusion abnormality commonly encountered in seizures was cortical ribboning, sparing the basal ganglia, and not respecting vascular territories. Large vessel CT Angiography (CTA) changes were absent. Conclusions: CTP is a valuable test to help differentiate strokes and seizures. CTP abnormalities are common in patients presenting to the ED with seizures. Particular attention to the patterns of CTP changes increases the specificity of this test. CTP imaging is now routinely available and has a shorter acquisition time than studies such as MRI or EEG making it uniquely useful for seizures. In addition, CTP may aid in targeting certain areas for biopsy in suspected pathologies like tumors and may prevent unnecessary thrombolysis. Given that cerebral blood flow mechanics is a dynamic phenomenon, the timing of CT perfusion is critical. We propose that there is likely a continuum of CTP changes in seizure: increased flow ictally, decreased flow post-ictally, and normalizing subsequently.

Disclosure: Dr. Khaku has nothing to disclose. Dr. Hedna has nothing to disclose. Dr. Waters has nothing to disclose.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/P3.005?rss=1

Implementation of Active Learning into the Pre-Clinical Neurology Undergraduate Medical Curriculum (P1.321)

Implementation of Active Learning into the Pre-Clinical Neurology Undergraduate Medical Curriculum (P1.321)
Neurology recent issues

ObjectiveTo report our experience transitioning a pre-clinical neurology medical school curriculum from a lecture-based to an active learning-based format.BackgroundActive learning is an educational model which accentuates student engagement and collaboration. While active learning has been the basis of clinical training, the focus of preclinical medical education has traditionally centered on group lectures. Neurologist educators have been urged to shift emphasis on teaching towards problem-based learning. We describe our experience implementing a transition to an active learning model.Design/methodsBetween 2010-2011 and 2011-2012, the preclinical neurology curriculum converted from traditional lectures to an active learning format. The neurology curriculum was divided into eleven four-hour blocks. Each block focused on a particular subtopic of neurology. Each block was preceded by a reading assignment and class time including group-response activity testing in which teams of 4-5 students worked collaboratively to answer case-based questions. This was followed by class discussion and a one hour traditional pathology lecture.ResultsOur preclinical neurology curriculum transitioned from traditional lecture to an active learning model. The student course pass rate did not decrease after the transition. USMLE step I neuroscience performance did not change significantly after the transition, but overall mean scores on the USMLE step I increased. Over 75% of the 35 students responding to an anonymous poll reported gaining more from the active learning format compared to traditional lectures. 60% of students felt a comfort level with active learning needed 2-3 weeks to occur.ConclusionsActive learning replaced traditional lecture-based learning for our US medical school preclinical neurology course. This transition occurred without a decrease in student pass rate or USMLE Step I scores, and was met with positive reviews from medical students.

Disclosure: Dr. Pula has nothing to disclose. Dr. Nixon has nothing to disclose. Dr. Aiyer has nothing to disclose. Dr. Kattah has received personal compensation for activities with Pfizer, Inc. as a consultant.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/P1.321?rss=1

NCSE in Neuro and Medical ICU Patients on Continous EEG Monitoring (P1.271)

NCSE in Neuro and Medical ICU Patients on Continous EEG Monitoring (P1.271)
Neurology recent issues

OBJECTIVE:Determine Incidence and Clinical outcome of Non Convulsive Status Epilepticus(NCSE) in Neuro and Medical ICU patients.BACKGROUND:NCSE is under recognized in critically ill patients and associated with significant morbidity and mortality.It often is only diagnosed with continous EEG monitoring.DESIGN/METHODS:Retrospective chart review study.Instituional IRB approval obtained.The EEG registry at University of Minnesota Medical Center was used to identify adult patients who underwent continuous EEG monitoring for at least 2 days in a Neuro or Medical ICU setting between 2005 and 2013. Exclusion criteria: Normal EEGEnd point:Discharge from hospital or death.Modified Rankin scale was used as a clinical outcome measure.SPSS was used for statistical analysisRESULTS:23.9%(21/88)were diagnosed with NCSE during continous EEG monitoring(19 of these 21 patients were in coma or stupor).Only 5 of these 21 patients had a known diagnosis of Epilepsy.Most common etiology in patients with NCSE was structural or traumatic brain injuries,(brain tumor,shunt malfunction,vascular malformation,subdural hematomas,traumatic SAH etc) followed by vascular and metabolic etiologies(9,4 and 4 patients respectively) only 1 patient had convulsive status epilepticus preceding NCSE.Patients diagnosed with NCSE did not have a worse clinical outcome per modified rankin scale(MRS)(p value 0.666),whereas patients in a state of stupor/coma(per clinical exam)did have a worse clinical outcome(p value < 0.005).CONCLUSIONS:NCSE was diagnosed in nearly one of four critically ill patients who underwent continous EEG most of whom did not have a prior diagnosis of Epilepsy.Most common etiology in the NCSE group was structural or traumatic brain injuries followed by vacular and metabolic etiologies.It was not clear that diagnosing NCSE changed clinical outcome in these patients.More studies including multicenter trials are needed to focus on Non convulsive status in critically ill patients.Study Supported by:Department of Neurology,University of Minnesota

Disclosure: Dr. Tom has nothing to disclose. Dr. Fiol-Elias has nothing to disclose.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/P1.271?rss=1

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
Neuro-Oncology - current issue



Original Article: http://neuro-oncology.oxfordjournals.org/cgi/content/short/16/5/696?rss=1

[Review] End-of-life decisions in patients with severe acute brain injury

[Review] End-of-life decisions in patients with severe acute brain injury
The Lancet Neurology

Most in-hospital deaths of patients with stroke, traumatic brain injury, or postanoxic encephalopathy after cardiac arrest occur after a decision to withhold or withdraw life-sustaining treatments. Decisions on treatment restrictions in these patients are generally complex and are based only in part on evidence from published work. Prognostic models to be used in this decision-making process should have a strong discriminative power. However, for most causes of acute brain injury, prognostic models are not sufficiently accurate to serve as the sole basis of decisions to limit treatment.

Original Article: http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70030-4/abstract?rss=yes

Monday, April 14, 2014

Neuro-oncology Telemedicine Follow-up Visits (I8-1.004)

Neuro-oncology Telemedicine Follow-up Visits (I8-1.004)
Neurology recent issues

OBJECTIVE: To determine whether neuro-oncology follow-up visits can be performed remotely using a videoconferencing system with high levels of safety and patient satisfaction.BACKGROUND: The Neuro-oncology Program at the Kaiser Permanente-Los Angeles Medical center serves the majority of Kaiser HMO patients with primary brain tumors in the Southern California region. We hypothesized that utilization of a videoconferencing system for follow-up visits would lead to high levels of patient satisfaction due to reduced travel time.DESIGN/METHODS: We installed a videoconferencing system (Cisco TelePresence EX90, Cisco Systems, San Jose, CA) in our office in Los Angeles and in a medical office building in Anaheim, CA at a distance of 35 miles. Established neuro-oncology patients from Orange County chose between in-person and remote visits. Patients were seated in an examination room and the neuro-oncologist alerted by text page. A focused history and physical examination was performed, followed by desktop sharing of clinical and laboratory data using an electronic medical record (Epic Systems Corporation, Verona, WI) and of neuroimages (Philips iSite PACS, Andover, MA). Patients completed an anonymous online 16 question satisfaction survey.RESULTS: Thirty-eight unique follow-up patients were evaluated by a single neuro-oncologist (R.G.). Sixty-nine patient visits were performed. Sixty-four visits included evaluation of neuroimaging and 23 visits included evaluation of response to ongoing chemotherapy. During 5 visits chemotherapy was started; during 5 other visits chemotherapy treatment was changed. Patients reported a high level of satisfaction with the visits (average 9.8, on a 1-10 scale). The average estimated travel time saved was 150 minutes per visit. Four surveys reported technical problems and 1 indicated a preference for an in-person visit. No adverse events could be attributed to use of the telemedicine system.CONCLUSIONS: These data suggest that neuro-oncology can be practiced safely and effectively using a telemedicine system, with high levels of patient satisfaction.

Disclosure: Dr. Green has nothing to disclose. Dr. Woyshner has nothing to disclose. Dr. Hauser Dehaven has nothing to disclose.



Original Article: http://www.neurology.org/cgi/content/short/82/10_Supplement/I8-1.004?rss=1

Tuesday, April 8, 2014

Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults

Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults
Journal of Neurosurgery: Journal of Neurosurgery: Pediatrics: Table of Contents

Journal of Neurosurgery: Pediatrics, Volume 13, Issue 4, Page 393-399, April 2014.
Object Ependymomas are a common type of CNS tumor in children, although only 13% originate from the spinal cord. Aside from location and extent of resection, the factors that affect outcome are not well understood. Methods The authors performed a search of an institutional neuropathology database to identify all patients with spinal cord ependymomas treated over the past 20 years. Data on patient age, sex, clinical presentation, symptom duration, tumor location, extent of resection, use of radiation therapy, surgical complications, presence of tumor recurrence, duration of follow-up, and residual symptoms were collected. Pediatric patients were defined as those 21 years of age or younger at diagnosis. The extent of resection was defined by the findings of the postoperative MR images. Results A total of 24 pediatric patients with spinal cord ependymomas were identified with the following pathological subtypes: 14 classic (Grade II), 8 myxopapillary (Grade I), and 2 anaplastic (Grade III) ependymomas. Both anaplastic ependymomas originated in the intracranial compartment and spread to the spinal cord at recurrence. The mean follow-up duration for patients with classic and myxopapillary ependymomas was 63 and 45 months, respectively. Seven patients with classic ependymomas underwent gross-total resection (GTR), while 4 received subtotal resection (STR), 2 received STR as well as radiation therapy, and 1 received radiation therapy alone. All but 1 patient with myxopapillary ependymomas underwent GTR. Three recurrences were identified in the Grade II group at 45, 48, and 228 months. A single recurrence was identified in the Grade I group at 71 months. The mean progression-free survival (PFS) was 58 months in the Grade II group and 45 months in the Grade I group. Conclusions Extent of resection is an important prognostic factor in all pediatric spinal cord ependymomas, particularly Grade II ependymomas. These data suggest that achieving GTR is more difficult in the upper spinal cord, making tumor location another important factor. Although classified as Grade I lesions, myxopapillary ependymomas had similar outcomes when compared with classic (Grade II) ependymomas, particularly with respect to PFS. Long-term complications or new neurological deficits were rare. Among patients with long-term follow-up, those who underwent GTR had a recurrence rate of 20% compared with 40% among those with STR or biopsy only, suggesting that extent of resection is perhaps a more important prognostic factor than histological grade in predicting PFS, which has been suggested by other data in the literature. Given the relative paucity of these lesions, collaborative multiinstitutional studies are needed, and such efforts should also focus on molecular and genetic analysis to refine the current classification system.

Original Article: http://thejns.org/doi/abs/10.3171/2013.12.PEDS13383?ai=3f6&mi=3ba5z2&af=R

Rolezinho na Neuro (PARTE 2) #rolezinho #livros #neuro

Rolezinho na Neuro (PARTE 2) #rolezinho #livros #neuro
Neurosurgery Blog

Olá Pessoal,

O Rolezinho na Neuro (parte 1) foi um sucesso. Enviamos mais de 20 livros para todo o Brasil sem  NENHUM CUSTO para quem recebeu.

Continuaremos agora com Rolezinho na Neuro (parte 2).

Para participar basta enviar um e-mail para neurocirurgiabr@gmail.com e contar por que você quer o livro. Infelizmente não tenho livro para todos mas irei tentar enviar mais 20 livros que escrevi. Segue abaixo os links dos livros.

OBS: Favor no email dizer qual livro você quer.

1044060_10152299962507577_418148290_n

Onde encontro os livros:
Após um tumor cerebralhttp://goo.gl/MJiTb2
Escrito em letra de médicohttp://goo.gl/Yuy5nV
Thoughts from the Hospitalhttp://goo.gl/goHz1O

Nas principais Livrarias:
Amazon: http://goo.gl/HIcf0B
Google Play: http://goo.gl/obwWHG
iBook: http://goo.gl/ThqLG1
Cultura: http://goo.gl/bvgJ5e
Saraiva: http://goo.gl/Wjw8Hi

 

 

The post Rolezinho na Neuro (PARTE 2) #rolezinho #livros #neuro appeared first on NEUROSURGERY BLOG.



Original Article: http://neurocirurgiabr.com/rolezinho-na-neuro-parte-2-rolezinho-livros-neuro/?utm_source=rss&utm_medium=rss&utm_campaign=rolezinho-na-neuro-parte-2-rolezinho-livros-neuro

International Issues: Obtaining an adult neurology residency position in the United States: An overview

International Issues: Obtaining an adult neurology residency position in the United States: An overview
Neurology current issue

Around the world, there are marked differences in neurology training, including training duration and degree of specialization. In the United States, adult neurology residency is composed of 1 year of internal medicine training (preliminary year) and 3 years of neurology-specific training. Child neurology, which is not the focus of this article, is 2 years of pediatrics and 3 years of neurology training. The route to adult neurology residency training in the United States is standardized and is similar to most other US specialties. Whereas US medical graduates often receive stepwise guidance from their medical school regarding application for residency training, international graduates often enter this complex process with little or no such assistance. Despite this discrepancy, about 10%–15% of residency positions in the United States are filled by international medical graduates.1,2 In adult neurology specifically, 35% of matched positions were filled by international graduates in 2013, 75% of whom were not US citizens.1 In an effort to provide a preliminary understanding of the application process and related terminology (table 1) and thereby encourage international residency applicants, we describe the steps necessary to apply for neurology residency in the United States.



Original Article: http://www.neurology.org/cgi/content/short/82/14/e112?rss=1

The history of brain retractors throughout the development of neurological surgery

The history of brain retractors throughout the development of neurological surgery
Journal of Neurosurgery: Neurosurgical FOCUS: Table of Contents

Neurosurgical Focus, Volume 36, Issue 4, Page E8, April 2014.
Early neurosurgical procedures dealt mainly with treatment of head trauma, especially skull fractures. Since the early medical writings by Hippocrates, a great deal of respect was given to the dura mater, and many other surgeons warned against violating the dura. It was not until the 19th century that neurosurgeons started venturing beneath the dura, deep into the brain parenchyma. With this advancement, brain retraction became an essential component of intracranial surgery. Over the years brain retractors have been created pragmatically to provide better visualization, increased articulations and degrees of freedom, greater stability, less brain retraction injury, and less user effort. Brain retractors have evolved from simple handheld retractors to intricate brain-retraction systems with hand-rest stabilizers. This paper will focus on the history of brain retractors, the different types of retractors, and the progression from one form to another.

Original Article: http://thejns.org/doi/abs/10.3171/2014.2.FOCUS13564?ai=rw&mi=3ba5z2&af=R

NIH Stem-Cell Program Closes

NIH Stem-Cell Program Closes
Scientific American: Mind and Brain

The director of the agency's Center for Regenerative Medicine resigned on March 28 after just one clinical-trial award had been made

-- Read more on ScientificAmerican.com


Original Article: http://www.scientificamerican.com/article/nih-stem-cell-program-closes/